TABLE 3.

Subgroup Analysis Outcome^a

Outcome: Study Design	Studies, n	Patients (BTB:HT), n	I 2, %	Risk Ratio (95% CI)	P Value
Graft failure
RCT	3	156:164	0	0.66 (0.41 to 1.06)	.09
Non-RCT	2	77:84	0	0.51 (0.20 to 1.29)	.16
Side-to-side difference
RCT	2	25:31	0	1.19 (0.46 to 3.08)	.72
Non-RCT	2	77:84	0	0.74 (0.37 to 1.50)	.41
Lachman test
RCT	1	21:27	NA	0.42 (0.02 to 9.92)	.59
Non-RCT	2	77:84	0	0.56 (0.29 to 1.09)	.09
Pivot-shift test
RCT	2	123:131	41	0.49 (0.10 to 2.40)	.38
Non-RCT	2	77:84	0	0.53 (0.24 to 1.16)	.11
Tegner score
RCT	2	123:131	77	0.67 (–0.64 to 1.99)	.32
Non-RCT	2	77:84	84	0.77 (–0.52 to 2.06)	.24
Lysholm score
RCT	1	21:23	NA	0.15 (–7.48 to 7.78)	.97
Non-RCT	2	77:84	9	–0.71 (–2.84 to 1.43)	.52

^aBPB, bone–patellar tendon–bone; HT, hamstring tendon; NA, not applicable; RCT, randomized controlled trial.